What is the latest ZOTA stock price?
The latest stored price for ZOTA is Rs 1,232.20 as of 2026-11-03.
gimli
ZOTA stock AI analysis
ZOTA Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ZOTA HEALTH CARE LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available ZOTA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹1,232.20
1W return
-3.73%
1M return
-2.81%
3M return
-2.65%
6M return
-6.03%
1Y return
-21.77%
Market cap
₹3,737.60 cr
PE
-36.14
PB
5.37
ROE
-22.40%
ROCE
-11.91%
RSI
45.68
Turnover
₹10.20 cr
Why it can matter in screens
- Momentum: ZOTA is above 50DMA, below 200DMA; RSI is 45.68.
- Returns: 1D +1.24%, 1W -3.73%, 1M -2.81%, 3M -2.65%, 1Y -21.77%.
- Trend levels: 52W high ₹1,483.60, 52W low ₹1,022.00, off high -16.95%.
- Liquidity: latest turnover is ₹10.20 cr; volume vs 20D is +1.00%.
- Valuation/profitability: PE -36.14, PB 5.37, ROE -22.40%, ROCE -11.91%.
- Growth: 3Y sales CAGR +56.70%, 3Y profit CAGR n/a.
Quick Answers
Is ZOTA above its 50DMA and 200DMA?
ZOTA is above 50DMA, below 200DMA. The latest 50DMA is 1,223.41 and the latest 200DMA is 1,252.75.
What are ZOTA PE, ROE and ROCE?
ZOTA has PE -36.14, ROE -22.40%, and ROCE -11.91% in Gimli's latest available snapshot.
How has ZOTA performed recently?
ZOTA has returned -2.81% over 1 month, -2.65% over 3 months, and -21.77% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 173.60 cr | -9.55 cr | -43.56 cr | -12.58 |
| 2026-03-31 | 163.18 cr | 5.91 cr | -14.17 cr | -4.13 |
| 2025-12-31 | 142.95 cr | 1.28 cr | -29.50 cr | -9.44 |
| 2025-09-30 | 130.59 cr | 7.96 cr | -16.19 cr | -5.02 |
| 2025-06-30 | 103.58 cr | 4.83 cr | -14.32 cr | -4.92 |
| 2025-03-31 | 97.27 cr | 3.47 cr | -12.89 cr | -4.57 |
| 2024-12-31 | 72.12 cr | -5.56 cr | -18.68 cr | -6.80 |
| 2024-09-30 | 67.28 cr | -0.33 cr | -12.10 cr | -4.57 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 538.66 cr | 19.98 cr | -73.94 cr | -22.46 |
| 2025-03-31 | 292.97 cr | -3.66 cr | -56.40 cr | -20.68 |
| 2024-03-31 | 180.49 cr | 8.21 cr | -14.35 cr | -5.59 |
| 2023-03-31 | 139.96 cr | 9.75 cr | -5.77 cr | -2.29 |
| 2022-03-31 | 133.18 cr | 16.36 cr | 10.58 cr | 3.58 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 1,131.05 cr | 7.77 cr | 270.44 cr | 696.17 cr |
| 2025-03-31 | 439.14 cr | 2.13 cr | 139.60 cr | 227.15 cr |
| 2024-03-31 | 228.33 cr | 0.68 cr | 95.28 cr | 89.98 cr |
| 2023-03-31 | 158.11 cr | 0.09 cr | 45.12 cr | 80.36 cr |
| 2022-03-31 | 139.09 cr | 0.04 cr | 14.90 cr | 89.63 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | -84.43 cr | -197.36 cr | n/a |
| 2025-03-31 | -49.96 cr | -95.94 cr | n/a |
| 2024-03-31 | -5.98 cr | -22.69 cr | n/a |
| 2023-03-31 | -2.01 cr | -14.51 cr | n/a |
| 2022-03-31 | 13.33 cr | 10.08 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +49.38% | +7.92% | +6.75% | +0.37% | +35.96% | +0.26% |
| 2026-03-31 | +49.38% | +8.21% | +6.40% | +0.37% | +36.00% | +0.26% |
| 2025-12-31 | +50.64% | +8.09% | +7.22% | +0.42% | +34.06% | +0.26% |
| 2025-12-17 | +51.56% | +8.00% | +6.09% | +0.45% | +34.35% | +0.00% |
| 2025-09-30 | +55.81% | +3.49% | +4.95% | +0.06% | +35.75% | +0.26% |
| 2025-06-30 | +57.42% | +3.82% | +4.25% | +0.00% | +34.52% | +0.26% |
| 2025-04-17 | +58.11% | +3.60% | +2.92% | +0.00% | +35.38% | +0.26% |
| 2025-03-31 | +59.72% | +0.87% | +3.08% | +0.03% | +36.33% | +0.26% |
| 2025-02-20 | +59.72% | +1.02% | +3.08% | +0.03% | +36.18% | +0.26% |
| 2024-12-31 | +62.02% | +0.24% | +1.03% | +0.02% | +36.71% | +0.26% |
| 2024-09-30 | +62.40% | +0.01% | +0.99% | +0.00% | +36.60% | +0.28% |
| 2024-08-14 | +62.40% | +0.02% | +0.76% | +0.00% | +36.82% | +0.28% |
| 2024-06-30 | +64.44% | +0.01% | +0.00% | +0.00% | +35.55% | +0.28% |
| 2024-04-06 | +64.45% | +0.00% | +0.00% | +0.00% | +35.55% | +0.28% |
| 2024-03-31 | +66.15% | +0.00% | +0.00% | +0.00% | +33.85% | +0.28% |
| 2023-12-31 | +66.15% | +0.00% | +0.00% | +0.00% | +33.85% | +0.28% |
| 2023-09-30 | +66.16% | +0.02% | +0.00% | +0.00% | +33.83% | +0.28% |
| 2023-07-18 | +66.16% | +0.04% | +0.00% | +0.00% | +33.81% | +0.27% |
| 2023-06-30 | +68.12% | +0.04% | +0.00% | +0.00% | +31.84% | +0.27% |
| 2023-03-31 | +68.12% | +0.00% | +0.00% | +0.00% | +31.88% | +0.27% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze ZOTA HEALTH CARE with valuation, momentum and industry peers
- Compare ZOTA with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ZOTA with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.